GLUCOSIDOS CARDIOTONICOS PDF

November 8, 2019 posted by

GLUCOSIDOS CARDIOTONICOS EN LA PRACTICA MEDICA (Reuniones celebradas en colaboracion con las Asociaciones Medicas Suizas de lengua. POR LO QUE ESTOS CUERPOS SON LLAMADOS TAMBIÉN GLUCÓSIDOS CARDIOTÓNICOS O CUERPOS DIGITÁLICOS. LOS CARDIOTÓNICOS SON. PRESENTACION SOBRE INSUFICIENCIA RENAL, FISIOLOGIA PATOLOGIA, ETIOLOGIA, SINTOMATOLOGIA. by lysique.

Author: Guran Tahn
Country: Bahrain
Language: English (Spanish)
Genre: Life
Published (Last): 15 June 2011
Pages: 455
PDF File Size: 12.52 Mb
ePub File Size: 1.9 Mb
ISBN: 477-7-78379-699-5
Downloads: 4115
Price: Free* [*Free Regsitration Required]
Uploader: Faeramar

Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions. Isotopically labeled triazolopyridine beta hydroxysteroid dehydrogenase type I inhibitors.

Thesaurus – G-Terms

Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases. Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists. Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders.

Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors. Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders. N- 4-sulfonylaryl Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists.

  A SYSTEMATIC THEORY OF ARGUMENTATION THE PRAGMA-DIALECTICAL APPROACH PDF

US USA en Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases. Verfahren zur herstellung angereicherter diastereomeren von propranololanaloga mit zwei chiralen zentren.

CURSO AUDIOVISUAL DE AUSCULTACION CARDIACA METODO GRANADA CUADERNILLO Y VIDEO

Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods. Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV. Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists. Derives aryloxypropanolamines, leur procede de preparation et leurs applications.

Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use.

Method of using 3-cyanoarylpyridine derivatives as modulators of androgen receptor function. Disubstituierte phenolaether des 3-aminohydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. Kind code of ref document: Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them.

Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein.

Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists. Complejos de aminoacidos de glucoxidos c-arilo para el tratamiento de la diabetes y procedimiento. Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations.

  FRACAS FAILURE REPORTING ANALYSIS CORRECTIVE ACTION SYSTEM PDF

Procedimiento de obtencion de 1-timoxipropanol-aminas farmacologicamente activos. Process for the preparation of amino acids useful in the preparation of peptide receptor modulators. A1 Designated state s: Processes and intermediates for the preparation of 5-[2- 4- benzoisothiazolyl -piperazinyl ethyl]chloro-1,3-dihydro-indolone.

Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions. Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant.

Ethanamine derivatives, their preparation and use in pharmaceutical compositions. Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method. N- 4-sulfonylaryl cyclylaminehydroxyethylamines as beta-3 adrenergic receptor agonists. Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV.